Cadwalader Advises Corindus Vascular Robotics in Its Definitive Agreement to Be Acquired by Siemens Healthineers AG
Cadwalader, Wickersham and Taft, a financial services law firm, issued the following news release:
Cadwalader advised Corindus Vascular Robotics (NYSE American: CVRS) in its definitive merger agreement to be acquired by Siemens Healthineers AG in a transaction valued at $1.1 billion.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company's CorPath(R) platform is the first FDA-cleared medical device to bring robotic preci...